BioSpace News Archive

Mallinckrodt Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy

The two-part multicenter study of 259 enrolled subjects showed >60 percent of patients achieved low disease activity (LDA) at week 12 with open-label therapy, an effect that was maintained in a proportion of patients with 12 additional weeks of treatment in the double-blind phase

April 15, 2020
·
17 min read
Pharm Country

Merck Announces US Launch of ONTRUZANT® (trastuzumab-dttb), a Biosimilar of Herceptin® (trastuzumab)

Merck, known as MSD outside the United States and Canada, announced the U.S. launch of ONTRUZANT, as a biosimilar of the reference biologic medicine Herceptin.

April 15, 2020
·
14 min read
Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer

Samsung Bioepis Co., Ltd. announced that ONTRUZANT®, a biosimilar of the reference biologic medicine HERCEPTIN®1 for the treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer or gastroesophageal junction adenocarcinoma, is now available in the United States.

April 15, 2020
·
7 min read
Business

Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020

Axogen, Inc. announced that it will report first quarter 2020 financial results on Wednesday, May 6, 2020 after the market closes.

April 15, 2020
·
2 min read
Business

Evelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer Industry veteran brings deep experience in drug development from leadership roles at Regeneron and Vertex

Evelo Biosciences, Inc. announced the appointment of biopharmaceutical industry veteran Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer and a member of the Evelo Executive Team.

April 15, 2020
·
3 min read
Business

Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources

Precision BioSciences, Inc., a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, announced that Dora Alvarado has joined the leadership team as Senior Vice President, Human Resources.

April 15, 2020
·
2 min read
BioMidwest

Bio-Techne’s Exosome Diagnostics Launches ExoDx Prostate At-Home Collection Kit

Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, is launching an ExoDx™ Prostate Test At-Home Collection Kit for patients who are concerned about their prostate health.

April 15, 2020
·
2 min read
BioMidwest

North Dallas Lab Pivots to Provide COVID-19 Testing to Area Hospitals and Doctors

RealTime Laboratories, Inc. performs tests for hospitals and doctors throughout the country and around the world.

April 15, 2020
·
1 min read
Business

STAAR Surgical to Report First Quarter Results on May 6, 2020

STAAR Surgical Company announced that it will release financial results for the first quarter ended April 3, 2020 on Wednesday, May 6, 2020 after the market close.

April 15, 2020
·
2 min read
Ceapro Inc. to Present at the April 2020 Virtual Investor Summit– Presentation with live audio webcast on Wednesday, April 22 at 1:00 PM ET, immediately followed by an interactive Q&A session –

Ceapro Inc. today announced that Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro will present at the April 2020 Virtual Investor Summit on Wednesday, April 22, 2020 at 1:00 PM ET. A live audio webcast of the

April 15, 2020
·
2 min read